Common use of Drug Testing Methodology Clause in Contracts

Drug Testing Methodology. 1. The testing or processing phase shall consist of a two-step procedure: a. initial screening test b. confirmation test 2. The urine sample is first tested using the initial drug screening procedure. An initial positive test result will not be considered conclusive; rather, it will be classified as "confirmation pending." Notification of test results to the supervisor or other departmental designee shall be held until the confirmation test results are obtained and verified by the M.R.O. 3. A specimen testing positive will undergo an additional confirmatory test. The confirmation procedure shall be technologically different and more sensitive than the initial screening test. 4. The drug screening tests selected shall be capable of identifying marijuana, cocaine and every major drug of abuse including heroin, amphetamines and barbiturates. Personnel utilized for testing will be certified as qualified to collect urine sample or adequately trained in collection procedures. 5. Concentrations of a drug at or about the following levels shall be considered a positive test result when using the initial immunoassay drug screening test: Marijuana metabolite . . . . . . . . . . 100 Cocaine metabolite . . . . . . . . . . . 300 Opiate metabolite. . . . . . . . . . . . 300* Phencyclidine. . . . . . . . . . . . . . 25 Amphetamines . . . . . . . . . . . . . . 1000 Barbiturates . . . . . . . . . . . . . . 300 *25ng/ml if immunoassay-specific for free morphine. Concentrations of a drug at or above the following levels shall be considered a positive test result when performing a confirmatory CG/MS test on a urine specimen that tested positive using a technologically different test than the initial screening method: Confirmatory Test Level Marijuana metabolite . . . . . . . . . . 15* Cocaine metabolite . . . . . . . . . . . 150** Opiates: Morphine. . . . . . . . . . . . . . 300+ Codeine . . . . . . . . . . . . . . 300+ Phencyclidine. . . . . . . . . . . . . . 25 Amphetamines Amphetamine . . . . . . . . . . . . 500 Methamphetamine . . . . . . . . . . 500 * Delta-9-tetrahydrocannabinol-9-carboxylic acid ** Benzoylecgonine + 25ng/ml if immunoassay-specific for free morphine

Drug Testing Methodology. 1. The testing or processing phase shall consist of a two-step procedure: a. initial screening test b. confirmation test 2. The urine sample is first tested using the initial drug screening procedure. An initial positive test result will not be considered conclusive; rather, it will be classified as "“confirmation pending." ” Notification of test results to the supervisor or other departmental designee shall be held until the confirmation test results are obtained and verified by the M.R.O. 3. A specimen testing positive will undergo an additional confirmatory test. The confirmation procedure shall be technologically different and more sensitive than the initial screening test. 4. The drug screening tests selected shall be capable of identifying marijuana, cocaine and every major drug of abuse including heroin, amphetamines and barbiturates. Personnel utilized for testing will be certified as qualified to collect urine sample samples, or adequately trained in collection procedures. 5. Concentrations of a drug at or about the following levels shall be considered a positive test result when using the initial immunoassay drug screening test: Initial Test Level (ng/ml) Marijuana metabolite metabolite. . . . . . . . . . . . 100 Cocaine metabolite metabolite. . . . . . . . . . . . . 300 Opiate metabolitemetabolite . . . . . . . . . . . . . . 300* PhencyclidinePhencyclidine . . . . . . . . . . . . . . . . . . 25 Amphetamines Amphetamines. . . . . . . . . . . . . . 1000 Barbiturates . . .1000 Barbiturates. . . . . . . . . . . . . . . . . . 300 *25ng/ml if immunoassay-specific for free morphine. Concentrations of a drug at or above the following levels shall be considered a positive test result when performing a confirmatory CG/MS test on a urine specimen that tested positive using a technologically different test than the initial screening method: Confirmatory Test Level Marijuana metabolite metabolite. . . . . . . . . . . . . . 15* Cocaine metabolite metabolite. . . . . . . . . . . . . . . . 150** Opiates: MorphineMorphine . . . . . . . . . . . . . . . . . . . . . 300+ Codeine Codeine. . . . . . . . . . . . . . . . . . . . . . . 300+ PhencyclidinePhencyclidine . . . . . . . . . . . . . . . . . . . . 25 Amphetamines Amphetamine . . . . . . . . . . . . . . . . . . 500 Methamphetamine . . . . . . . . . . . . . . 500 * Delta-9-tetrahydrocannabinol-9-carboxylic acid ** Benzoylecgonine + 25ng/ml if immunoassay-specific for free morphinemorphine Barbiturates. . . . . . . . . . . . . . . . . . . . . . .300 6. The laboratory selected to conduct the analysis shall be experienced and capable of quality control, documentation, chain-of-custody, technical expertise and demonstrated proficiency in urinalysis. 7. Employees having negative drug test results shall receive a memorandum stating that no illegal drugs were found. A copy of the letter will be placed in the Employee’s personnel file upon the Employee’s request. 8. Any employee who interferes with the testing process or breaches the confidentiality of test results shall be subject to discipline.

Drug Testing Methodology. 1. The testing or processing phase shall consist of a two-step procedure: a. initial screening test b. confirmation test 2. The urine sample is first tested using the initial drug screening procedure. An initial positive test result will not be considered conclusive; rather, it will be classified as "confirmation pending." Notification of test results to the supervisor or other departmental designee shall be held until the confirmation test results are obtained and verified by the M.R.O. 3. A specimen testing positive will undergo an additional confirmatory test. The confirmation procedure shall be technologically different and more sensitive than the initial screening test. 4. The drug screening tests selected shall be capable of identifying marijuana, cocaine and every major drug of abuse including heroin, amphetamines and barbiturates. Personnel utilized for testing will be certified as qualified to collect urine sample or adequately trained in collection procedures. 5. Concentrations of a drug at or about the following levels shall be considered a positive test result when using the initial immunoassay drug screening test: Initial Test Level (ng/ml) Marijuana metabolite . . . . . . . . . . 100 Cocaine metabolite . . . . . . . . . . . 300 Opiate metabolite. . . . . . . . . . . . 300* Phencyclidine. . . . . . . . . . . . . . 25 Amphetamines . . . . . . . . . . . . . . 1000 Barbiturates . . . . . . . . . . . . . . 300 *25ng/ml if immunoassay-specific for free morphine. Concentrations of a drug at or above the following levels shall be considered a positive test result when performing a confirmatory CG/MS test on a urine specimen that tested positive using a technologically different test than the initial screening method: Confirmatory Test Level Marijuana metabolite . . . . . . . . . . 15* Cocaine metabolite . . . . . . . . . . . 150** Opiates: Morphine. . . . . . . . . . . . . . 300+ Codeine . . . . . . . . . . . . . . 300+ Phencyclidine. . . . . . . . . . . . . . 25 Amphetamines Amphetamine . . . . . . . . . . . . 500 Methamphetamine . . . . . . . . . . 500 * Delta-9-tetrahydrocannabinol-9-carboxylic acid ** Benzoylecgonine + 25ng/ml if immunoassay-specific for free morphineLevel